Health Care

At Blue Light News Summit, top drug lobbyist calls Trump’s efforts to codify his signature drug pricing deals ‘the wrong policy prescription’

Published

3 hours ago

on

PhRMA CEO Stephen Ubl applauded the Trump administration for pressuring other nations to pay more, but says he is against efforts to make White House “most-favored-nation” agreements permanent
Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version